Mandate

Vinge has advised Main Capital and Björn Lundén in connection with the acquisition of Due Compliance AB

Due Compliance is a software company which enables organisations to comply with the requirements in relation to Money Laundering and Terrorist Financing (Prevention) Act by providing digital tools for AML, KYC and Risk Assessments.

Björn Lundén, which is a strong provider of software for accounting, invoicing and payroll management, considers the acquisition of Due Compliance as an important step towards expanding its offering of digital tools in the regulatory market. The acquisition strengthens the group’s market position with the goal of becoming a leading player in Europe offering a comprehensive set of cloud-based accounting, ERP and RegTech solutions.
Vinge’s team consisted of Filip Öhrner, Josef Groow (M&A), Arvid Weimers, Karl-Gustaw Tobola, August Ahlin (Banking and Finance), Lisa Hörnqvist (IT and GDPR), Axel Lennartsson (IP), Victor Björkheim (employment) and Jessica Öijer (Transaction Support Senior Specialist).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025